Penumbra, Inc. (BMV:PEN)

Market Cap	223.82B +1.9%
Revenue (ttm)	26.22B +17.3%
Net Income	3.08B +305.0%
EPS	78.20 +302.4%
Shares Out	n/a
PE Ratio	72.58
Forward PE	60.59
Dividend	n/a
Ex-Dividend Date	n/a

Volume	300
Average Volume	446
Open	4,775.70
Previous Close	4,911.82
Day's Range	4,775.70 - 4,775.70
52-Week Range	3,904.75 - 4,911.82
Beta	n/a
RSI	55.88
Earnings Date	Jul 30, 2026

About Penumbra

Penumbra, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. It offers computer-assisted vacuum thrombectomy; peripheral thrombectomy products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombectomy system; and CAT RX. It also provides access products, including guide catheters and the Penumbra distal delivery catheters under the Neuron, Neuron ...

• Industry: Surgical and Medical Instruments and Apparatus
• Founded: 2004
• Employees: 4,700
• Stock Exchange: Mexican Stock Exchange
• Ticker Symbol: PEN

Financial Performance

In 2025, Penumbra's revenue was $1.40 billion, an increase of 17.50% compared to the previous year's $1.19 billion. Earnings were $177.69 million, an increase of 1168.11%.

Financial numbers in USD